CXCL9 Antikörper
(1 reference)-
- Target Alle CXCL9 Antikörper anzeigen
- CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CXCL9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Functional Studies (Func)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Immunogen
- Recombinant human CXCL9
- Isotyp
- IgG
- Top Product
- Discover our top product CXCL9 Primärantikörper
-
anti-gamma-Interferon-Induced Monokine (CXCL9) (AA 23-125) antibody
CXCL9 Reaktivität: Human, Maus, Ratte, Schwein WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) (AA 90-125) antibodyCXCL9 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) antibodyCXCL9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C7 unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) (AA 22-126) antibodyCXCL9 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) (AA 22-125) antibodyCXCL9 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) (AA 96-122), (C-Term) antibodyCXCL9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB26207 unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) (N-Term) antibodyCXCL9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) (AA 23-125) antibodyCXCL9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) (AA 23-125) antibodyCXCL9 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-gamma-Interferon-Induced Monokine (CXCL9) (AA 23-125) antibody (FITC)CXCL9 Reaktivität: Human WB Wirt: Kaninchen Polyclonal FITC
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- 1.0 mg/mL
-
-
: "Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis." in: Rheumatology (Oxford, England), Vol. 53, Issue 1, pp. 104-13, (2013) (PubMed).
-
: "Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis." in: Rheumatology (Oxford, England), Vol. 53, Issue 1, pp. 104-13, (2013) (PubMed).
-
- Target
- CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))
- Andere Bezeichnung
- CXCL9 (CXCL9 Produkte)
- Synonyme
- CMK antikoerper, Humig antikoerper, MIG antikoerper, SCYB9 antikoerper, crg-10 antikoerper, BB139920 antikoerper, Mig antikoerper, MuMIG antikoerper, Scyb9 antikoerper, C-X-C motif chemokine ligand 9 antikoerper, chemokine (C-X-C motif) ligand 9 antikoerper, CXCL9 antikoerper, Cxcl9 antikoerper
- Hintergrund
- Synonyms: MIG
- Gen-ID
- 4283
- UniProt
- Q07325
-
